Olivia Moody
Affiliations: | 2018- | Anesthesiology | MGH/BWH/Harvard Medical School |
Google:
"Olivia Moody"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kallay L, Keskin H, Ross A, et al. (2019) Modulating native GABA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death. Journal of Neuro-Oncology |
| Moody OA, Jenkins A. (2018) The role of loops B and C in determining the potentiation of GABA receptors by midazolam. Pharmacology Research & Perspectives. 6: e00433 |
| Butler KM, Moody OA, Schuler E, et al. (2018) De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Brain : a Journal of Neurology |
| Kallay L, Keskin H, Ross A, et al. (2018) PDTM-45. POSITIVE MODULATION OF NATIVE GABAA RECEPTORS IN MEDULLOBLASTOMA CANCER CELLS WITH BENZODIAZEPINES INDUCES RAPID MITOCHONDRIAL FRAGMENTATION AND TP53-DEPENDENT, CELL CYCLE-INDEPENDENT APOPTOSIS Neuro-Oncology. 20: vi213-vi213 |
| Moody OA, Talwar S, Jenkins MA, et al. (2017) Rigor, Reproducibility and in vitro CSF assays: The Devil in the Details. Annals of Neurology |
| Kallay L, Ross A, Moody O, et al. (2017) PATH-50. UNDERSTANDING THE MECHANISM OF BENZODIAZEPINE MEDIATED CELL DEATH IN GABRA5 OVEREXPRESSING GROUP 3 MEDULLOBLASTOMAS Neuro-Oncology. 19: vi182-vi182 |
| McConnell O, Wang E, Bassell G, et al. (2017) Impaired consciousness states in myotonic dystrophy-type 1 mediation by γ-amino butyric acid (GABA) Sleep Medicine. 40: e285 |
| Kolb I, Stoy WA, Rousseau EB, et al. (2016) Cleaning patch-clamp pipettes for immediate reuse. Scientific Reports. 6: 35001 |
| Kolb I, Stoy WA, Rousseau E, et al. (2016) Cleaning Patch Clamp Pipettes Enables their Reuse Biophysical Journal. 110: 149a |
| Yuan H, Low CM, Moody OA, et al. (2015) Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Molecular Pharmacology. 88: 203-17 |